Lannett Company, Inc.
NYSE: LCI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Timothy C. Crew
- Employees
- 564
- Headquarters
- Trevose, United States
- IPO year
- 2013
- Market cap
- $7.4M
- Website
- https://www.lannett.com
Loading LCI…
Loading profile data…Frequently asked questions about LCI
What does Lannett Company, Inc. (LCI) do?
Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to the comprehensive process of developing, manufacturing, packaging, commercializing, and distributing generic versions of established brand-name drugs. Its extensive product portfolio encompasses a wide array of dosage forms, including solid oral, extended-release, to...
Where does LCI trade?
Lannett Company, Inc. (LCI) trades on the New York Stock Exchange.
What sector is LCI in?
Lannett Company, Inc. (LCI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lannett Company, Inc.?
Timothy C. Crew is the chief executive officer of Lannett Company, Inc. (LCI).
Where is Lannett Company, Inc. headquartered?
Lannett Company, Inc. is headquartered in United States.
Does LCI pay a dividend?
Lannett Company, Inc. (LCI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LCI go public?
Lannett Company, Inc. (LCI) completed its initial public offering in 2013.